TrialThe Lancet. Global health2025

Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial.

Jackie K Patterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.